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Abstract
Background: In temperate climates, invasive meningococcal disease (IMD) incidence tends to coincide with or closely follow
peak incidence of influenza virus infection; at a seasonal level, increased influenza activity frequently correlates with
increased seasonal risk of IMD.
Methods: We evaluated 240 cases of IMD reported in central Ontario, Canada, from 2000 to 2006. Associations between
environmental and virological (influenza A, influenza B and respiratory syncytial virus (RSV)) exposures and IMD incidence
were evaluated using negative binomial regression models controlling for seasonal oscillation. Acute effects of weekly
respiratory virus activity on IMD risk were evaluated using a matched-period case-crossover design with random
directionality of control selection. Effects were estimated using conditional logistic regression.
Results: Multivariable negative binomial regression identified elevated IMD risk with increasing influenza A activity (per 100
case increase, incidence rate ratio=1.18, 95% confidence interval (CI): 1.06, 1.31). In case-crossover models, increasing
weekly influenza A activity was associated with an acute increase in the risk of IMD (per 100 case increase, odds ratio (OR)
=2.03, 95% CI: 1.28 to 3.23). Increasing weekly RSV activity was associated with increased risk of IMD after adjusting for RSV
activity in the previous 3 weeks (per 100 case increase, OR=4.31, 95% CI: 1.14, 16.32). No change in disease risk was seen
with increasing influenza B activity.
Conclusions: We have identified an acute effect of influenza A and RSV activity on IMD risk. If confirmed, these finding
suggest that influenza vaccination may have the indirect benefit of reducing IMD risk.
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Introduction
Neisseria meningitidis is a leading cause of meningitis and
bacteremia worldwide [1]. Invasive meningococcal disease
(IMD) may be epidemic (e.g., in sub-Saharan Africa) or endemic
(e.g., Canada and the United States). Infection occurs most
commonly in infants and young children, with a second peak in
incidence observed among adolescents and young adults [1,2].
Incidence of IMD has declined in some regions recently [3], but
the high case-fatality rates associated with infection [1] and the risk
of transmission to contacts make IMD a disease of continuing
public health importance.
Invasive meningococcal disease (IMD) displays marked season-
ality; in temperate climates, IMD incidence tends to peak in late
winter and early spring [1,2]. As with other infectious diseases
demonstrating seasonal periodicity, the mechanisms driving these
fluctuations remain poorly understood. Environmental exposures,
including relative humidity [4,5,6,7,8,9] and ultraviolet radiation
[9], may contribute to IMD seasonality, although these effects
appear to be regionally specific in direction and magnitude.
However, other seasonal exposures have also been postulated to
drive the seasonality of IMD: surges in IMD activity frequently
coincide with or closely follow increases in the incidence of
influenza and other respiratory virus infections [10,11,12,13], with
elevated IMD risk reported when influenza activity is ‘‘epidemic’’
[14]. This association has led some investigators to suggest that
influenza activity may directly influence invasive meningococcal
disease risk [10], but evidence for acute effects of changing
influenza activity on invasive meningococcal disease risk has to
date been limited. This correlated incidence of viral infections and
IMD could represent a causal link, but could also represent shared
susceptibility to seasonal environmental exposures or seasonal
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e15493changes in human behavior (e.g., clustering together of individuals
indoors due to cold winter weather, holiday gatherings, etc.).
Approaches to the evaluation of links between respiratory viral
disease incidence and IMD risk need to be able to adjust for
expected crude correlations between multiple seasonally occurring
respiratory diseases and environmental exposures. We have
previously used regression models with seasonal smoothers, and
case-crossover analyses, to evaluate the association between
environmental exposures and bacterial respiratory disease
[9,15,16]. The case-crossover study design provides a means of
evaluating causal relationships between rare outcomes, such as
invasive meningococcal disease, and brief, transient exposures,
such as fluctuating levels of influenza activity, or environmental
conditions [9,16]. We used the case-crossover design, as well as
more traditional regression methods, to evaluate the impact of
influenza and respiratory syncytial virus (RSV) on meningococcal
disease risk in Central Ontario, Canada.
Methods
For the purposes of this study, Central Ontario, Canada, was
defined as the Greater Toronto Area (GTA) and contiguous
jurisdictions (Figure 1). Approximately 68% of the population of
the province of Ontario resides within this area, representing over
8.15 million individuals in 2006 [17].
Case identification
Cases of IMD occurring in Ontario between January 2000 and
December 2006 were retrospectively identified through the
Ontario Public Health Laboratory System, a provincial reference
laboratory that performs all reference testing on meningococcal
isolates in the province [3]. Patient characteristics, submission date
and disease outcome were ascertained from patient requisitions
and electronic databases used for the reporting of notifiable
diseases in Ontario: the Reportable Disease Information System
(RDIS) (2000–2005) and the integrated Public Health Information
System (iPHIS) (2006).
Exposure estimates
Weekly influenza A and B test volumes and test results (using
viral culture or direct antigen detection) for the GTA and RSV
virus activity estimates for the province of Ontario were obtained
from sentinel laboratories that participate in the Public Health
Agency of Canada’s Respiratory Virus Detection Surveillance
System (RVDSS) for the time period under investigation. The
RVDSS is perhaps best known for the support it provides to
Canada’s ‘‘FluWatch’’ influenza surveillance system [18].
We obtained time series data on ultraviolet radiation and
weather from Environment Canada monitoring stations in the
GTA (Table 1). Where daily readings were taken at multiple
locations, the arithmetic means of environmental data were used
as exposure variables.
Statistical analyses
We evaluated seasonality of IMD, influenza, and RSV
occurrence by calculating autocorrelation coefficients for case
counts aggregated at weekly and monthly levels, through spectral
decomposition, and by the incorporation of Fourier transform
Figure 1. Map of Ontario, Canada, showing Central Ontario and the Greater Toronto Area, as defined in this study.
doi:10.1371/journal.pone.0015493.g001
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periodicity was not apparent in the IMD dataset, and because data
were too skewed for the use of Poisson regression, we modeled
underlying trends in IMD occurrence using negative binomial
regression models incorporating restricted cubic splines as
smoothers. The optimal model was determined based on
minimization of Akaike’s Information Criterion and incorporated
spline knots at six-month intervals [9]. Models incorporated
population data derived from the 2001 and 2006 censuses as
offsets, with linear interpolation and extrapolation used to
generate population denominators for non-census years. The
impact of environmental and virological exposures (i.e., level of
influenza and/or RSV activity) was assessed by incorporating
these terms into models containing spline terms. Exposures were
incorporated into models using a backward elimination algorithm,
with covariates retained in the final model for P#0.05 [20].
To evaluate acute associations between influenza and RSV
activity and occurrence of individual cases, we used a case-
crossover approach. This study design is similar to the case-control
design, except that it uses self-matching rather than an external
control group [21,22]. This approach reduces confounding by
participant characteristics that remain constant over time, while
essentially eliminating the risk of selecting unrepresentative
controls [21]. A 2:1 matched-period case-crossover design was
used. Hazard periods (person-time during which the event
occurred) were defined according to date of symptom onset.
Beginning on January 1, 2000, person-time at risk was divided into
3-week time blocks. The two days within each block that could be
matched to the hazard period by day-of-week were defined as
control days (person-time during which the event of interest did
not occur). Each analytic stratum consisted of one case day and
two control days. This approach was used to produce random
directionality of control period selection, since seasonal or
temporal trends may introduce bias when only unidirectional or
stereotyped bidirectional control periods are used in the context of
exposure data with underlying temporal trends [23].
Given the incubation period for IMD (typically ,7 days) [1] we
considered exposures occurring within 1 week of case occurrence
to fall within plausible effect periods. As respiratory virus infection
prevalence was only available as weekly totals, concurrent week
respiratory virus exposures were used to estimate effects. Effects
were also explored at longer lags (up to 3 weeks prior to case
occurrence). We performed both univariable and multivariable
analyses (i.e., models restricted to respiratory viruses at single lags,
as well as models that included respiratory virus effects at multiple
lags and environmental covariates).
Odds ratios for caseoccurrence, based on influenzaor RSV activity,
were estimated using conditional logistic regression, with standard
errors adjusted for clustering by 3-week time blocks [20]. We explored
possible heterogeneity of effect by serogroup or case occurrence during
influenza season (November through April) versus non-influenza
season using stratum-specific analyses, with heterogeneity of effects
across strata assessed using the meta-analytic Q-statistic [24]. We
explored the possibility of effect modification by age by incorporating
multiplicative interaction terms into the regression models.
Results
Case Characteristics
Between 2000 and 2006, 240 meningococcal cases were
identified in Central Ontario (Table 2), with a crude annual rate
of 4.4 cases per million population (95% confidence interval (CI):
3.9, 5.0). The median age of cases was 23 years (range: ,1 month
to 98 years). Risk was not significantly higher in women than in
men (incidence rate ratio (IRR) =1.27, 95% CI: 0.98, 1.64). The
majority of cases were positive for serogroups B (33%) and C
(30%). There was an annual trend of decreasing yearly incidence
of IMD during the study period (IRR=0.90, 95% CI: 0.84, 0.97),
as reported elsewhere [9].
Seasonality of Invasive Meningococcal Disease
Case occurrence was significantly increased in the winter
months (December, January, and February, mean annualized
incidence (cases per million) 5.7, 95% CI: 3.6, 7.8) relative to the
autumn (September, October, November, mean annualized
incidence (cases per million) 3.1, 95% CI: 2.7, 6.3; IRR=1.73,
95% CI: 1.20, 2.50). No significant differences in incidence were
observed for the spring (mean annualized incidence (cases per
million) 4.5, 95% CI: 2.7, 6.3) and summer months (mean
annualized incidence (cases per million) 4.4, 95% CI 2.8, 6.0),
Table 1. Sources and measurement sites for exposure variables.
Variable Measurement site Source
VIrologic data Public Health Agency of Canada[18]
Influenza A and B activity Greater Toronto Area
RSV activity Ontario
Weather data Toronto Canadian National Climate Archive [36]
Maximum temperature,uC
Mean temperature, uC
Maximum relative humidity, %
Snowfall, mm
Rainfall, mm
Ultraviolet (UV) data Toronto Environment Canada—World Ozone and
UV Data Centre [37]
UV index, per unit change
UVA index, per unit change
UVB index, per unit change
doi:10.1371/journal.pone.0015493.t001
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IMD was observed, either through spectral decomposition or
construction of autocorrelograms, evidence of significant annual
seasonal oscillation was observed when Fourier transform terms
were added to the model (P-value for seasonal oscillation with
combined sine and cosine terms=0.013).
Influenza A, influenza B, and RSV all showed strong winter and
spring time seasonality, with annual shifts in the timing and height
of peak activity during the study period (Figure 2). Annual
periodicity was observed for RSV, with maximum autocorrelation
observed at week 52 (autocorrelation coefficient=0.71). For
influenza B, maximum autocorrelation was observed at week 51
(autocorrelation coefficient=0.43). Periodicity of influenza A was
less regular, with maximum autocorrelation observed at week 60
(autocorrelation coefficient=0.33). Negative binomial models also
showed strong statistical evidence for annual oscillation for all
three respiratory viruses (P ,0.001).
Negative binomial regression
Univariable negative binomial regression models identified an
association between risk of IMD and increasing weekly influenza A
activity the week of, and two weeks prior to, case occurrence, and
RSV activity during the week of case occurrence only (Table 3).
Statistically significant associations between several environmental
exposures and IMD risk were also identified in univariable models.
However, in multivariable models that incorporated cubic spline
smoothers, only influenza A activity the week prior to case
occurrence was an independent predictor of IMD risk (per 100
case increase, IRR=1.18, 95% CI: 1.06, 1.31). The effect size
Table 2. Characteristics of cases of invasive meningococcal
disease (n=240) in Central Ontario, Canada, 2000–2006.
Characteristic No. of Cases (%)
Total 240
Sex
Male 102 (42.5)
Female 138 (57.5)
Age, years
0 – 4 46 (19.2)
5 – 9 11 (4.6)
10 – 14 9 (3.7)
15 – 19 29 (12.1)
20 – 24 30 (12.5)
25 – 64 70 (29.2)
$65 37 (15.4)
Not reported 8 (3.3)
Neisseria meningitidis serogroup
B 80 (33.3)
C 72 (30.0)
W-135 27 (11.2)
Y 58 (24.2)
Other/unknown 3 (1.3)
doi:10.1371/journal.pone.0015493.t002
Figure 2. Annualized rates of invasive meningococcal disease (IMD) (right axis) and influenza A, influenza B, and RSV (left axis)
between 2000 and 2006. IMD cases are for reported Central Ontario, while influenza A and B activity is reported for the Greater Toronto Area, and
RSV activity is reported for the province of Ontario.
doi:10.1371/journal.pone.0015493.g002
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other lags (IRR 1.81, 95% CI 0.92 to 3.56), though the effect
ceased to be statistically significant (P=0.085), likely reflecting a
high-degree of autocorrelation in RSV exposure in the time-series
(P#0.004 for lags of 1, 2, and 3 weeks).
Case-crossover analysis
We estimated effects of respiratory virus activity up to 3 weeks
prior to case occurrence (see Figures S1, S2, and S3 for
unadjusted results). Increasing weekly influenza A activity during
the week of case occurrence was associated with an acute increase
in the risk of invasive meningococcal disease (per 100 case
increase, OR=2.03, 95% CI: 1.28, 3.23; adjusted for previous 3
weeks of influenza A activity, OR=2.46, 95% CI: 1.34, 4.48)
(Figure 3(a)). Increasing influenza A activity the week prior to
case occurrence was associated with an increased risk of IMD (per
100 case increase, OR=1.53, 95% CI: 1.03, 2.26), but this effect
disappeared after adjusting for influenza activity during the week
of case occurrence. In contrast to negative binomial models,
increasing RSV activity during the week of IMD case occurrence
was associated with increased risk of IMD only after adjusting for
RSV activity in prior weeks (unadjusted, per 100 case increase,
OR=1.92, 95%CI: 0.75, 4.93; adjusted for previous 3 weeks of
RSV activity, OR=4.31, 95% CI: 1.14, 16.32) (Figure 3(b)). No
change in meningococcal disease risk was observed with increasing
influenza B activity.
Adjustment for other environmental exposures previously
demonstrated to be associated with IMD risk, including ultraviolet
radiation [9] and relative humidity [4,5,6,7,8,9] did not alter the
observed effects. No differences in effect were observed in analyses
by serogroup or by influenza season versus non-influenza season.
No modification of effect was observed by age group.
Discussion
The co-seasonality of respiratory viruses and invasive menin-
gococcal disease has long been recognized [13,25], but establishing
the causal nature of this relationship has remained difficult due to
the relatively stereotyped late wintertime appearance of both
diseases. Using both regression models that incorporate smoothers,
and a complementary case-crossover study design, we have
demonstrated that increases in influenza A and RSV activity at
the population level increase the risk of IMD in Central Ontario
even after adjustment for expected temporal trends (in the case of
Table 3. Variables significantly associated with the occurrence of invasive meningococcal disease in univariable and multivariable
negative binomial regression models, Central Ontario, 2000–2006.
Variable Univariable Models Multivariable Models with Restricted Cubic Splines
IRR 95% CI P-value IRR 95% CI P-value
Influenza A, per 100 cases
No lag 1.17 1.06 to 1.29 0.002 --- --- ---
1 week lag 1.17 1.07 to 1.29 0.001 1.18 1.06 to 1.31 0.003
2 week lag 1.16 1.04 to 1.28 0.005 --- --- ---
RSV, per 100 cases
No lag 1.27 1.03 to 1.56 0.023 --- --- ---
Maximum temperature
(uC)
0.98 0.97 to 0.99 0.006 --- --- ---
Rainfall (mm) 0.92 0.84 to 0.99 0.031 --- --- ---
doi:10.1371/journal.pone.0015493.t003
Figure 3. Association between respiratory virus activity and
invasive meningococcal disease in Central Ontario, 2000–2006.
Odds ratios are plotted on a log scale and are reported per 100 reported
cases of (a) influenza A and (b) RSV, while lag times (in weeks) are
plotted on the x-axis. An increased risk of IMD was seen with increasing
influenza A and RSV activity during the week of case occurrence. Odds
ratios are adjusted for respiratory virus activity in the remaining weeks.
95% confidence intervals are indicated by bars.
doi:10.1371/journal.pone.0015493.g003
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crossover models). By contrast, we identified no association
between the incidence of influenza B virus infection and IMD risk.
Our findings reproduce earlier work completed in Denmark
and Spain [12,14]; both of these earlier studies used regression
methods with oscillatory seasonal smoothers to demonstrate links
between surges in influenza activity and IMD risk after controlling
for predictable co-seasonality. Such regression methods require
aggregation of case data and exposures, leading to possible
‘‘ecological fallacy’’ [26]. Case-only methods, such as case-
crossover design, may reduce distortions caused by data
aggregation, and permit analysis of environmental factors
associated with case occurrence at the level of the individual
[27]. The ‘‘self-matching’’ characteristic of the case-crossover
design also reduces confounding by season. For example, in our
study, case periods are matched to control periods that are 7–14
days away in time and matched by day-of-week; as such, our
estimates would not be confounded by seasonal factors (e.g., school
attendance) that would not vary over short time periods.
Our case-crossover findings were consistent with effects
identified using regression models (i.e., increased risk of IMD
with increased influenza A and RSV activity), and do not appear
to be attributable to variation in environmental exposures (such as
UV radiation) which we adjusted for in our analyses. We note that
our findings with RSV were somewhat less clear-cut than those
seen with influenza, which may reflect a higher degree of
autocorrelation in the RSV time series than in the influenza time
series, with resultant distortion of effects when exposures at
multiple lags were introduced into models.
Understanding the mechanisms through which influenza and
RSV alter the epidemiology of IMD will have important
implications for disease control. Viral infection of the upper
respiratory mucosa has been proposed to enhance adherence of N.
meningitidis to respiratory epithelium [28,29]. In vitro experimen-
tation has demonstrated enhancement of adhesion of N. meningitidis
capsule to cultured epithelial cells when influenza A virus
neuraminidase is present [29]. RSV-infected cells also appear to
have enhanced binding to N. meningitidis (and H. influenzae, another
important cause of bacterial meningitis) to a larynx-derived cell
culture [28]. By contrast, Read and colleagues failed to find any
effect of experimental infection with influenza B viruses on
interaction between N. meningitidis and respiratory epithelium [30].
Interestingly influenza B incidence (in contrast to influenza A and
RSV incidence) was not associated with changes in IMD risk in
our study, although this could have been due to issues of statistical
power, as influenza B incidence was lower than incidence of
influenza A in our time series.
If the findings reported here can be confirmed, they have
important implications for disease control policy. While vaccina-
tion against IMD appears to have resulted in important reductions
in morbidity and mortality in the province of Ontario [3], the most
commonly invasive serogroup in the province is now B, which is
not incorporated into the recently introduced quadrivalent vaccine
(although promising vaccines against serogroup B are in
development [31]). Our findings suggest that influenza prevention
via vaccine programs may provide an additional indirect benefit to
the province by reducing the risk of IMD in some individuals.
Targeting of influenza vaccination at younger individuals in the
context of both seasonal and pandemic influenza has been
identified as an approach that is possibly more effective at
preventing morbidity than direct targeting of older individuals,
who are less likely to develop a protective immune response to
vaccine [32,33,34]. Our observations suggest that an additional
indirect benefit of vaccinating younger individuals could include
reduction of IMD risk. While the environmental nature of
influenza circulation in the community, as represented in this
study, makes calculation of attributable risk complex, the
ubiquitous nature of influenza suggests that the influenza-
attributable fraction of IMD, which would be the fraction of
IMD cases that can be eliminated by eliminating influenza
transmission, is likely to be high, even for modest elevations in
relative risk [35].
Like any observational epidemiological study relying on
surveillance data, our study has limitations. Our case-crossover
approach serves only as a partial remedy to issues of ecological
fallacy related to data aggregation, as our influenza and RSV
exposures are available at the weekly, rather than daily, level.
Furthermore, respiratory viral activity levels are derived from a
provincial system, whereas IMD cases reside only in the central
part of the province. This latter issue is not likely to serve as an
important source of bias, as most of Ontario’s population resides in
the central part of the province. Finally, due to the aggregated
nature of influenza exposure data, we are unable to define a
precise effect period that might provide insights into whether this
effect is driven by increased transmission, increased propensity for
invasive disease, or increased colonization, though biological
experiments described above strongly suggest that the latter may
be important.
In summary, we identified strong associations between influenza
and RSV activity and risk of invasive meningococcal disease in the
Canadian province of Ontario. These effects persisted after
adjusting for coincident environmental factors and using both
smoothers and a case-crossover approach to minimize confound-
ing. Such effects are biologically plausible, and have important
implications for development of vaccines and disease control
policy targeted at reducing the burden of these important
infectious diseases.
Supporting Information
Figure S1 Association between influenza A activity and invasive
meningococcal disease. Crude odds ratios per 100 cases of
influenza A are shown for the week of IMD case occurrence
(week 0) and for lags of up to 3 weeks prior to case occurrence.
Odds ratios are not adjusted for influenza A activity in the
remaining weeks and are plotted on a log scale. Lag times (in
weeks) are plotted on the x-axis. 95% confidence intervals are
indicated by bars. (TIF)
Figure S2 Association between influenza B activity and invasive
meningococcal disease. Crude odds ratios per 100 cases of
influenza B are shown for the week of IMD case occurrence
(week 0) and for lags of up to 3 weeks prior to case occurrence.
Odds ratios are not adjusted for Influenza B activity in the
remaining weeks and are plotted on a log scale. Lag times (in
weeks) are plotted on the x-axis. 95% confidence intervals are
indicated by bars. (TIF)
Figure S3 Association between RSV activity and invasive
meningococcal disease. Crude odds ratios per 100 cases of RSV
are shown for the week of IMD case occurrence (week 0) and for
lags of up to 3 weeks prior to case occurrence. Odds ratios are not
adjusted for RSV activity in the remaining weeks and are plotted
on a log scale. Lag times (in weeks) are plotted on the x-axis. 95%
confidence intervals are indicated by bars. (TIF)
Author Contributions
Conceived and designed the experiments: ART STK AM DNF. Analyzed
the data: ART DNF. Contributed reagents/materials/analysis tools: LMK
FJ JFK AM . Wrote the paper: ART LMK DNF.
Respiratory Virus Infection and IMD Risk
PLoS ONE | www.plosone.org 6 November 2010 | Volume 5 | Issue 11 | e15493References
1. Baltimore R (1998) Meningococcal infections. In: Evans AS, Brachman PS, eds.
Bacterial infections of humans: epidemiology and control. 3rd ed. New York:
Plenum Publishing Corp. pp 459–479.
2. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM (2001)
Meningococcal disease. N Engl J Med 344: 1378–1388.
3. Kinlin LM, Jamieson F, Brown EM, Brown S, Rawte P, et al. (2009) Rapid
identification of herd effects with the introduction of serogroup C meningococcal
conjugate vaccine in Ontario, Canada, 2000-2006. Vaccine 27: 1735–1740.
4. Sultan B, Labadi K, Guegan JF, Janicot S (2005) Climate drives the meningitis
epidemics onset in west Africa. PLoS Med 2: e6.
5. Block C, Roitman M, Bogokowsky B, Meizlin S, Slater PE (1993) Forty years of
meningococcal disease in Israel: 1951-1990. Clin Infect Dis 17: 126–132.
6. Lindsay AP, Hope V, Marshall RJ, Salinger J (2002) Meningococcal disease and
meteorological conditions in Auckland, New Zealand. Aust N Z J Public Health
26: 212–218.
7. Michele M, Alberto M, Liana S, Francesco D (2006) Do environmental factors
influence the occurrence of acute meningitis in industrialized countries? An
epidemic of varying aetiology in Northern Italy. Eur J Epidemiol 21: 465–468.
8. Collier CG (1992) Weather conditions prior to major outbreaks of meningo-
coccal meningitis in the United Kingdom. Int J Biometeorol 36: 18–29.
9. Kinlin LM, Spain CV, Ng V, Johnson CC, White AN, et al. (2009)
Environmental exposures and invasive meningococcal disease: an evaluation
of effects on varying time scales. Am J Epidemiol 169: 588–595.
10. Cartwright KA, Jones DM, Smith AJ, Stuart JM, Kaczmarski EB, et al. (1991)
Influenza A and meningococcal disease. Lancet 338: 554–557.
11. Hubert B, Watier L, Garnerin P, Richardson S (1992) Meningococcal disease
and influenza-like syndrome: a new approach to an old question. J Infect Dis
166: 542–545.
12. JensenES, Lundbye-Christensen S,Samuelsson S, Sorensen HT, Schonheyder HC
(2004) A 20-year ecological study of the temporal association between influenza and
meningococcal disease. Eur J Epidemiol 19: 181–187.
13. Young LS, LaForce FM, Head JJ, Feeley JC, Bennett JV (1972) A simultaneous
outbreak of meningococcal and influenza infections. N Engl J Med 287: 5–9.
14. Dominguez A, Munoz P, Cardenosa N, Martinez A, Cayla J (2007) Time-series
analysis of meningococcal disease in Catalonia. Ann Epidemiol 17: 654–662.
15. Ng V, Tang P, Jamieson F, Drews SJ, Brown S, et al. (2008) Going with the flow:
legionellosis risk in Toronto, Canada is strongly associated with local watershed
hydrology. Ecohealth 5: 482–490.
16. White AN, Ng V, Spain CV, Johnson CC, Kinlin LM, et al. (2009) Let the sun
shine in: effects of ultraviolet radiation on invasive pneumococcal disease risk in
Philadelphia, Pennsylvania. BMC Infect Dis 9: 196.
17. Statistics Canada (2009) Health regions: boundaries and correspondence with
census geography - census data. Available: http://www.statcan.gc.ca/pub/82-
402-x/2009001/cs-eng.htm. Accessed 2010 Feb 12.
18. Public Health Agency of Canada (2010) FluWatch. Available: http://www.
phac-aspc.gc.ca/fluwatch/index-eng.php. Accessed 2010 Mar 24.
19. Fisman DN (2007) Seasonality of infectious diseases. Annu Rev Public Health
28: 127–143.
20. Hosmer DW, Lemeshow S (1989) Applied logistic regression. New York: John
Wiley & Sons, Inc. xiii, 307 p.
21. Maclure M (1991) The case-crossover design: a method for studying transient
effects on the risk of acute events. Am J Epidemiol 133: 144–153.
22. Maclure M, Mittleman MA (2000) Should we use a case-crossover design? Annu
Rev Public Health 21: 193–221.
23. Levy D, Lumley T, Sheppard L, Kaufman J, Checkoway H (2001) Referent
selection in case-crossover analyses of acute health effects of air pollution.
Epidemiology 12: 186–192.
24. Deeks J, Altman D (1995) Effect measures for meta-analysis of trials with binary
outcomes. In: Egger M, Davey Smith G, Altman D, eds. Systematic Reviews in
Health Care: Meta-Analysis in Context. London, UK: BMJ Publishing Group.
pp 313–335.
25. Lal HB, Narayan TK, Kalra SL, Lal R (1963) Simultaneous outbreaks of
influenza and meningitis. J Indian Med Assoc 40: 113–115.
26. Jackson ML (2009) Confounding by season in ecologic studies of seasonal
exposures and outcomes: examples from estimates of mortality due to influenza.
Ann Epidemiol 19: 681–691.
27. Soverow JE, Wellenius GA, Fisman DN, Mittleman MA (2009) Infectious
disease in a warming world: how weather influenced West Nile virus in the
United States (2001-2005). Environ Health Perspect 117: 1049–1052.
28. Raza MW, El Ahmer OR, Ogilvie MM, Blackwell CC, Saadi AT, et al. (1999)
Infection with respiratory syncytial virus enhances expression of native receptors
for non-pilate Neisseria meningitidis on HEp-2 cells. FEMS Immunol Med
Microbiol 23: 115–124.
29. Rameix-Welti MA, Zarantonelli ML, Giorgini D, Ruckly C, Marasescu M, et al.
(2009) Influenza A virus neuraminidase enhances meningococcal adhesion to
epithelial cells through interaction with sialic acid-containing meningococcal
capsules. Infect Immun 77: 3588–3595.
30. Read RC, Goodwin L, Parsons MA, Silcocks P, Kaczmarski EB, et al. (1999)
Coinfection with influenza B virus does not affect association of Neisseria
meningitidis with human nasopharyngeal mucosa in organ culture. Infect Immun
67: 3082–3086.
31. Sadarangani M, Pollard AJ (2010) Serogroup B meningococcal vaccines-an
unfinished story. Lancet Infect Dis 10: 112–124.
32. Galvani AP, Reluga TC, Chapman GB (2007) Long-standing influenza
vaccination policy is in accord with individual self-interest but not with the
utilitarian optimum. Proc Natl Acad Sci U S A 104: 5692–5697.
33. Loeb M, Russell ML, Moss L, Fonseca K, Fox J, et al. (2010) Effect of influenza
vaccination of children on infection rates in Hutterite communities: a
randomized trial. JAMA 303: 943–950.
34. Medlock J, Galvani AP (2009) Optimizing influenza vaccine distribution.
Science 325: 1705–1708.
35. Szklo M, Nieto F (2000) Measuring associations between exposures and
outcomes. Epidemiology: Beyond the Basics. 1st ed. Gaithersburg, MD: Aspen.
pp 91–121.
36. Environment Canada (2010) National climate data and information archive.
Available: http://www.climate.weatheroffice.gc.ca/Welcome_e.html. Accessed
2010 Feb 11.
37. Fioletov VE, Kimlin MG, Krotkov N, McArthur LJB, Kerr JB, et al. (2004) UV
index climatology over the United States and Canada from ground-based and
satellite estimates. J Geophys Res 109: D22308.
Respiratory Virus Infection and IMD Risk
PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e15493